| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 01/03/2024 | 23h04 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 02/12/2023 | 02h31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 02/12/2023 | 02h31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 16/11/2023 | 23h11 | Edgar (US Regulatory) | Form 8-K - Current report | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 15/11/2023 | 13h19 | InvestorsHub NewsWire | Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 09/11/2023 | 22h30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 09/11/2023 | 14h00 | InvestorsHub NewsWire | Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 07/11/2023 | 13h29 | InvestorsHub NewsWire | Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 09/08/2023 | 22h36 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 06/04/2023 | 01h32 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 05/04/2023 | 15h31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 13/03/2023 | 12h35 | InvestorsHub NewsWire | Nightfood, Inc. (OTCQB: NGTF) now in Sonesta International Hotels Multiple Brands | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 28/02/2023 | 22h31 | Edgar (US Regulatory) | Annual Report (10-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 07/02/2023 | 23h55 | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 13/01/2023 | 22h34 | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 06/01/2023 | 22h42 | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 23/12/2022 | 23h24 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 16/12/2022 | 19h40 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 05/12/2022 | 13h01 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 01/12/2022 | 16h29 | TipRanks | Northwest Bio Accuses Market Makers of Share Price Manipulation | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 25/11/2022 | 23h30 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 09/11/2022 | 22h31 | Edgar (US Regulatory) | Quarterly Report (10-q) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 27/09/2022 | 15h33 | InvestorsHub NewsWire | Acquisition Completed: Endexx (EDXC)'s HYLA Secures 200k+ Unit Order; 4,500 Puffs per Unit | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 30/06/2022 | 23h09 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 10/05/2022 | 12h02 | Edgar (US Regulatory) | Quarterly Report (10-q) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 02/05/2022 | 23h05 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 12/04/2022 | 14h30 | InvestorsHub NewsWire | TNS Issues New Reports on Stocks with Potential Near Term Catalysts and a Feature Green Energy NASDAQ Report | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 17/03/2022 | 13h00 | InvestorsHub NewsWire | TNS Feature Report and Next Gen Tech and Biotech That Could Change Our Lives | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 04/03/2022 | 15h11 | InvestorsHub NewsWire | Seeking Alpha - ALYI sees substantial interest for new EV taxi program | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
| 01/03/2022 | 18h49 | Edgar (US Regulatory) | Annual Report (10-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |